Transdermal Radiofrequency V ERASER Versus Polidocanol Sclerotherapy for Reticular Veins and Telangiectasias

NCT06962813 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
46
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Science Valley Research Institute